Table 1 Characteristics of the study population
From: No differences in FBN1 genotype between men with and without abdominal aortic aneurysm
AAA | Control | p value | |
|---|---|---|---|
n = 159 | n = 70 | ||
Age, years | 70 ± 3.9 | 68 ± 2.9 | < 0.001 |
BMI, kg/m2 | 28.1 ± 4.3 | 27.0 ± 3.5 | 0.046 |
CRP, mg/L | 4.5 ± 6.3 | 2.8 ± 3.5 | 0.004 |
ApoB/ApoA | 0.66 ± 1.1 | 0.73 ± 0.18 | 0.193 |
Diabetes, n (%) | 12 (7.5) | 3 (4.3) | 0.823 |
Hypertension, n (%) | 128 (80.5) | 27 (38.6) | < 0.001 |
Hyperlipidaemia, n (%) | 102 (64.2) | 15 (21.4) | < 0.001 |
AHT, n (%) | 89 (56) | 21 (30.0) | < 0.001 |
ACE inhibitors, n (%) | 78 (49.1) | 22 (31.4) | 0.012 |
Beta-blockers, n (%) | 68 (42.8) | 14 (20.0) | < 0.001 |
Calcium antagonists, n (%) | 43 (27.0) | 8 (11.4) | 0.008 |
Diuretics, n (%) | 34 (21.4) | 3 (4.3) | < 0.001 |
Statins, n (%) | 114 (71.7) | 17 (24.3) | < 0.001 |
Aspirin, n (%) | 96 (60.4) | 12 (17.1) | < 0.001 |
Smokers, n (%) | |||
Current | 97 (61) | 21 (30) | < 0.001 |
Former | 39 (24.5) | 5 (7.1) | < 0.001 |